Case Study: an Indian research hospital advances solid tumor profiling with SOPHiA GENETICS

Indian Research Hospital analyzes 42 DNA variants and 137 RNA fusions with SOPHiA GENETICS

An Indian research hospital with over 75 years of experience sought a comprehensive and user-friendly analytical solution for solid tumor profiling using next-generation sequencing. Confused by other solutions with limitations in variant identification, the institution needed genomic applications that included detailed molecular profiling and a list of fusions, leading them to vendor SOPHiA GENETICS and its SOPHiA DDM™ Solid Tumor Plus Solution.

SOPHiA GENETICS implemented its platform, which precisely assesses DNA-based variants and RNA-based gene fusion events. The solution provided accurate detection of various genetic alterations and a unique community frequency tool to assess variant frequency both within the hospital's cohort and globally. The hospital benefited from secure data ownership, trusted third-party insights for confident decision-making, and prompt support from SOPHiA GENETICS throughout the entire user experience.